BioSpace News Archive

Drug Development

Synthetic Biologics’ SYN-004 (Ribaxamase) Achieves Primary Endpoint In Phase 2b Trial For C. Difficile Infection (CDI)

January 5, 2017
·
9 min read
Business

Amorsa Therapeutics Announces Strategic Collaboration Facilitated By Johnson & Johnson Innovation To Develop New Therapy For Treatment-Resistant Depression

January 5, 2017
·
1 min read
Deals

Abbott Completes The Acquisition Of St. Jude Medical

January 5, 2017
·
4 min read
Business

AOBiome Partners With iCarbonX And Secures $30 Million Investment For Drug Development

January 5, 2017
·
2 min read
Drug Development

Soligenix Receives Positive Scientific Advice From The EMA For SGX942 In The Treatment Of Oral Mucositis In Head And Neck Cancer Patients

January 5, 2017
·
10 min read
Business

VolitionRX Strengthens Team With Key Appointment To Drive Sales And Trials In Asia

January 5, 2017
·
6 min read
Business

GenVec Signs Option Agreement For Gene Editing And Cell Targeting Technology From Washington University in St. Louis

January 5, 2017
·
4 min read
Drug Development

Otonomy Announces Positive Top-Line Results From Phase III Clinical Trial of OTIPRIO in Patients With Acute Otitis Externa

January 5, 2017
·
7 min read
Deinove Release: A First Innovative Antibiotic Candidate Patented

January 5, 2017
·
2 min read
Business

Bay Area Startup BlackThorn Therapeutics Nabs Another $14 Million, Bringing Its Series A Total to $54 Million

January 5, 2017
·
2 min read